Stocks To Watch Today: Jio Financial Services, Medplus Health, JK Tyre, HCLTech
Jio Financial Services Ltd., Medplus Health Services Ltd. and Neuland Laboratories Ltd. are some stocks that will be on the radar on Wednesday.
Jio Financial Services and BlackRock further subscribed to Rs 5.85 crore shares of JV Jio BlackRock Asset Management for Rs 117 crore, while Medplus Health's arm gets three suspension orders of drug licence for store situated in Karnataka.
Neuland Laboratories board approved capital expenditure of Rs 342 crore in two facilities.
Stocks To Watch
Jio Financial Services: The company and BlackRock further subscribed to Rs 5.85 crore shares of JV Jio BlackRock Asset Management for Rs 117 crore.
Medplus Health Services: The company's arm gets three suspension orders of drug licence for store situated in Karnataka.
Neuland Laboratories: The company's board approved capital expenditure of Rs 342 crore in two facilities.
JK Tyre Industries: The company received a $100 million sustainability-linked loan from International Finance Corp. The funding includes $30 million for the company and up to $70 million for its arm Cavendish Industries.
Centum Electronics: The company further invested up to €2 million in Centum T&S Group SA via its arm.
HCL Technologies: The company launched a 5,000-people delivery centre in Hyderabad.
Tanla Platforms: The company approved the sale of a 100% stake in arm Gamooga Softtech to another arm, Karix Mobile.
Vodafone Idea: The company received GST demand order worth Rs 8.9 crore, including interest, from the Mumbai government.
Zydus Lifesciences: The company's arm received a demand order with a penalty of Rs 16.6 lakh for fiscal 2018-19 on an issue about alleged excess availment of ITC.
Vedanta: Unit Balco received a GST demand order of Rs 22 lakh, including interest, from the Delhi government.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.